Literature DB >> 34315949

Lowering DNA binding affinity of SssI DNA methyltransferase does not enhance the specificity of targeted DNA methylation in E. coli.

Krystyna Ślaska-Kiss1, Nikolett Zsibrita1,2, Mihály Koncz1,2, Pál Albert1,2, Ákos Csábrádi1, Sarolta Szentes1, Antal Kiss3.   

Abstract

Targeted DNA methylation is a technique that aims to methylate cytosines in selected genomic loci. In the most widely used approach a CG-specific DNA methyltransferase (MTase) is fused to a sequence specific DNA binding protein, which binds in the vicinity of the targeted CG site(s). Although the technique has high potential for studying the role of DNA methylation in higher eukaryotes, its usefulness is hampered by insufficient methylation specificity. One of the approaches proposed to suppress methylation at unwanted sites is to use MTase variants with reduced DNA binding affinity. In this work we investigated how methylation specificity of chimeric MTases containing variants of the CG-specific prokaryotic MTase M.SssI fused to zinc finger or dCas9 targeting domains is influenced by mutations affecting catalytic activity and/or DNA binding affinity of the MTase domain. Specificity of targeted DNA methylation was assayed in E. coli harboring a plasmid with the target site. Digestions of the isolated plasmids with methylation sensitive restriction enzymes revealed that specificity of targeted DNA methylation was dependent on the activity but not on the DNA binding affinity of the MTase. These results have implications for the design of strategies of targeted DNA methylation.
© 2021. The Author(s).

Entities:  

Year:  2021        PMID: 34315949     DOI: 10.1038/s41598-021-94528-3

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  32 in total

Review 1.  Notes on the role of dynamic DNA methylation in mammalian development.

Authors:  Timothy H Bestor; John R Edwards; Mathieu Boulard
Journal:  Proc Natl Acad Sci U S A       Date:  2014-11-03       Impact factor: 11.205

Review 2.  Advances of epigenetic editing.

Authors:  Rutger A F Gjaltema; Marianne G Rots
Journal:  Curr Opin Chem Biol       Date:  2020-06-30       Impact factor: 8.822

Review 3.  Eukaryotic cytosine methyltransferases.

Authors:  Mary Grace Goll; Timothy H Bestor
Journal:  Annu Rev Biochem       Date:  2005       Impact factor: 23.643

4.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

5.  Stable oncogenic silencing in vivo by programmable and targeted de novo DNA methylation in breast cancer.

Authors:  S Stolzenburg; A S Beltran; T Swift-Scanlan; A G Rivenbark; R Rashwan; P Blancafort
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

6.  Repurposing the CRISPR-Cas9 system for targeted DNA methylation.

Authors:  Aleksandar Vojta; Paula Dobrinić; Vanja Tadić; Luka Bočkor; Petra Korać; Boris Julg; Marija Klasić; Vlatka Zoldoš
Journal:  Nucleic Acids Res       Date:  2016-03-11       Impact factor: 16.971

7.  Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors.

Authors:  Emily A Saunderson; Peter Stepper; Jennifer J Gomm; Lily Hoa; Adrienne Morgan; Michael D Allen; J Louise Jones; John G Gribben; Tomasz P Jurkowski; Gabriella Ficz
Journal:  Nat Commun       Date:  2017-11-13       Impact factor: 14.919

Review 8.  DNA methylation and de-methylation using hybrid site-targeting proteins.

Authors:  Yong Lei; Yung-Hsin Huang; Margaret A Goodell
Journal:  Genome Biol       Date:  2018-11-06       Impact factor: 13.583

9.  Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing.

Authors:  Angelo Amabile; Alessandro Migliara; Paola Capasso; Mauro Biffi; Davide Cittaro; Luigi Naldini; Angelo Lombardo
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

10.  Epigenome engineering: new technologies for precision medicine.

Authors:  Agustin Sgro; Pilar Blancafort
Journal:  Nucleic Acids Res       Date:  2020-12-16       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.